Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN114591302B. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114591302B reveals a novel synthesis for high-purity antiviral intermediates, offering significant cost reduction and supply chain reliability for global pharmaceutical manufacturers.